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Abstract 
Lutein has been shown to preferentially accumulate in the macula of the neural retina as 
macular pigment and across all brain cortices of infants and adults. This preferential 
accumulation in the brain has led to the hypothesis that lutein may positively impact cognition, 
possibly through its anti-inflammatory and/or antioxidant properties.  Both macular pigment 
optical density (MPOD) – a non-invasive measure of retinal lutein and correlate of brain lutein – 
and dietary lutein supplementation have been associated with better cognitive function among 
adult populations. However, the reliability of heterochromatic flicker photometry (HFP) to 
measure MPOD has only recently been demonstrated to be a moderately reliable technique in 
preadolescent children. Therefore, to date, the relationship between MPOD and cognitive 
performance has not been directly investigated in children. Accordingly, the main objective of 
this thesis was to investigate the relationship between MPOD, assessed and averaged over two 
time points using HFP, and academic performance among 8-10-year-olds (N = 56). Additional 
objectives were to investigate how MPOD relates with dietary intake of lutein and zeaxanthin, 
and to determine if lutein and zeaxanthin intake would mediate the relationship between MPOD 
and academic performance. Academic performance was assessed using the Kaufman Test of 
Academic and Educational Achievement II (KTEA). Habitual dietary intake of lutein and 
zeaxanthin was measured using the average of 3-day food records. The results for the main 
objective of this thesis indicated a significant correlation between MPOD and the KTEA 
composite measures of achievement (r = 0.40, P < 0.01), reading (r = 0.28, P = 0.04), math (r = 
0.35, P < 0.01), and written language (r = 0.41, P < 0.01), but not with reading fluency (r = 0.22, 
P = 0.11). Further analysis with stepwise hierarchical regression models was conducted with sex, 
intelligence quotient (IQ), whole body percent fat, and fat free mass VO2max included in the 
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initial step.  Subsequent addition of MPOD into the model was conducted to determine the 
contribution to the academic measures following adjustments of related variables. The addition 
of MPOD did not statistically improve the explained variance for the reading or reading fluency 
composite scores. However, the adding of MPOD in the model did explain additional variance 
for the achievement composite standard scores (ΔR2 = 0.10, P < 0.01), math composite standard 
scores (ΔR2 = 0.07, P = 0.02), and the written language composite standard scores (ΔR2 = 0.15, P 
< 0.01). Further, the composite measures were decomposed to investigate whether the subtests 
all had similar relations with MPOD as their composite scores. The results indicated that all 
subtests were consistent with their composite measures. For the additional objectives the results 
showed the dietary consumption of lutein and zeaxanthin was positively correlated with MPOD 
(r = 0.39, P = 0.02).  Lutein and zeaxanthin intake was significantly related with the written 
language composite score (r = 0.53, P < 0.01), but not with any of the other academic composite 
scores. Stepwise regressions completed in a subset of children to assess if lutein and zeaxanthin 
intake would mediate the relationship between MPOD and academics, showed that MPOD’s 
relationship to academics still remained following adjustment for dietary intake. The 
accumulation of this evidence indicates that macular lutein is associated with superior 
performance on academic measures, particularly in math and written language while dietary 
intake had weaker relationships. This is the first study to demonstrate that retinal lutein and 
zeaxanthin, measured as MPOD, is related to academic achievement in children. This has 
implications as the macular pigment can be influenced by the diet in most of the population. 
However, this conclusion is tenuous and should be investigated further by conducting placebo-
controlled interventions.  
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CHAPTER 1 – INTRODUCTION 
Carotenoids are a family of fat-soluble plant pigments that have received considerable 
investigation for their beneficial effects on a variety of chronic diseases (1). Interestingly, though 
there are over 700 carotenoids in nature, only about 40 are found in the typical diet and of those 
40, only 20 can be found in human blood and tissue (2, 3). The carotenoids, from the xanthophyll 
class, lutein, zeaxanthin, and meso-zeaxanthin accumulate at the macula to the exclusion of all 
other carotenoids (4, 5). Collectively, they are known as the macular pigment. Lutein and 
zeaxanthin are entirely of dietary origin, while meso-zeaxanthin is believed to be present due to 
the bioconversion of lutein (4). Dietary sources of lutein and zeaxanthin include fruits and 
vegetables of various colors as well as eggs (6).  
Lutein and zeaxanthin have been demonstrated to be of importance to retinal health (7). 
The macular pigment filters damaging blue light, wavelengths between 430 and 490nm with a 
maximum absorption at 465nm (8), and it has antioxidant properties that protect the retina from 
photo-oxidative damage (9-11). Macular pigment optical density (MPOD) has been associated 
with faster visual processing speed (12), reduced glare (13), better visual performance when 
ambient illumination is low (14), improved contrast sensitivity (15), reduced symptoms of visual 
fatigue (16), and increased neuronal signaling efficiency in the eye (17). 
In non-human primates, MPOD has been found to serve as a good proxy for the amount 
of lutein and zeaxanthin in the brain (18), thus allowing MPOD to be used as a biomarker of 
lutein and zeaxanthin concentration in the brain. Recent studies in both the elderly and infants 
have found that much of the concentration of carotenoids in the brain is dominated by lutein. 
Lutein has been found to preferentially accumulate in the infant brain, accounting for 59% of 
total carotenoids in the brain while only constituting 12% of the infants’ carotenoid intake (19). 
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The relative contribution of lutein to the total carotenoids in infant brains is almost two-fold 
greater than in adults, accounting for 59% vs. 34%, respectively (19, 20), suggesting a selective 
neuroprotective role of lutein in early neural development.  
Many direct and indirect measures of macular pigment optical density have been 
associated with better cognitive function among older adults (20-24). In a large prospective 
cohort, older adults consuming the highest amounts of vegetables had a slower rate of cognitive 
decline over 6 years, and green leafy vegetables had the strongest relationship (21). Six of eight 
measured cognitive functions, including measures of global cognition, verbal learning and 
fluency, recall, processing speed, and perceptual speed, were significantly correlated with 
MPOD (22). On the other hand, in this study the relationship with serum lutein and zeaxanthin 
was not as consistent to the cognitive measures, and serum levels only related to verbal fluency 
(22).  Another study demonstrated that lower MPOD values were significantly associated with 
worse performance on tests of global cognitive function, processing speed, prospective memory, 
and executive function (23). In the Georgia Centenarian Study postmortem brain samples that 
contained higher concentrations of lutein and zeaxanthin were associated with better cognitive 
function at the time of death (20). Finally, lutein supplementation has been shown to improve 
verbal fluency among older women (24). Given this accumulating evidence for lutein’s impact 
on cognitive function of the elderly, and since lutein is found at higher relative concentrations in 
the infant brain than the elderly brain, it is a natural extension to ask the scientific question of 
whether the relationship between MPOD and cognitive abilities exists during childhood.  
Performance on standardized academic achievement tests have been demonstrated to 
have reliable relationships with many facets of life, including academic and job performance 
(25). Since the implementation of the No Child Left Behind (NCLB) Act of 2001, schools have 
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been under increasing pressure by federal law to deliver on academic milestones, prompting 
many schools to alter nutrition during the days before standardized testing to boost short-term 
performance (26). Thus, with the external pressure on schools to provide students with a basic 
academic skill set and the known relationships between current academic performance and future 
success in life, it is crucial to provide evidence-based dietary guidance to support children’s 
abilities for long-term scholastic success. Although a growing body of literature supports the role 
that overall diet quality and breakfast consumption have on improved academic performance (27, 
28), the influence of habitual intake of specific nutrients on academic success remains largely 
unknown. 
 MPOD is a tool for examining the habitual intake of lutein and zeaxanthin as it is more 
of a stable measure of intake than serum or blood, and it allows for a better representation for 
long-term intake of these nutrients (22).  Accordingly, the major aim of this thesis was to 
determine whether MPOD was associated with academic performance. Secondary aims were to: 
(1) determine if dietary intake of lutein and zeaxanthin are related to MPOD measures, and (2) 
assess whether the relationship between MPOD and academics is mediated by dietary intake of 
lutein and zeaxanthin. Due to MPOD having significant positive associations with cognition in 
adults, and infants having higher brain levels of lutein as percent of carotenoids than the elderly, 
we hypothesized that higher MPOD would be associated with superior performance on 
standardized academic achievement tests among a sample of preadolescent children (8-9-year-
olds). Further, we hypothesized that dietary measures would relate to MPOD, as they have in 
some previous adult studies (29), and that dietary intake would partially mediate the relationship 
between MPOD and academics, as intake of dietary lutein and zeaxanthin has been shown to 
contribute to MPOD in most of the population (30). The findings from these objectives are 
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important because they may shine light on whether current dietary intake, or potential previous 
intakes and early life factors, impact macular pigment in preadolescence. Additionally, these 
objectives contribute to how these factors impact performance on academic measures. To date 
there is no Daily Reference Intake (DRI) for lutein and/or zeaxanthin. Thus, the more studies that 
are completed showing the significance of these xanthophylls, the closer the support will be for 
completing the DRI process.  
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CHAPTER 2 – REVIEW OF THE LITERATURE  
 Given the available literature for lutein and zeaxanthin, diet relationships with cognition 
in children, and macular pigment optical density (MPOD) relationships to diet and cognition in 
adults, it is necessary to review the literature-base to provide a foundation for the present thesis. 
Specifically, this review will provide an overview of lutein and zeaxanthin. Next, the literature 
investigating dietary factors and their relationships with cognition in children will be reviewed to 
demonstrate why a noninvasive technique to measure MPOD in children would be advantageous. 
Then, an overview of MPOD history, the relationship between MPOD to diet, and finally, 
MPOD associations with cognition in adults will be discussed.  
Lutein and Zeaxanthin  
Structure and Sources 
 Carotenoids are richly colored molecules, and they are responsible for the yellow, orange, 
and red colors found in many plants (31). There are more than 700 carotenoids found in nature 
(3). Among these, only two accumulate in the macular pigment, and thus this review will only 
focus on those two pigments, lutein and zeaxanthin (32). Lutein and zeaxanthin are structural 
isomers. They have the chemical formula C40H56O2. When examining their structures, lutein and 
zeaxanthin are the dihydroxy derivatives of α-carotene and β-carotene, respectively (33). While 
both α-carotene and β-carotene act as provitamin A carotenoids, lutein and zeaxanthin do not 
despite their structural similarities (34).  All carotenoids are hydrocarbons, and they are divided 
into two subgroups: carotenes, which are oxygen free, and xanthophylls that are oxygenated. 
Both lutein and zeaxanthin are xanthophylls (35). Due to the presence of their hydroxy groups 
xanthophylls are more polar than carotenes (33). As a result of lutein and zeaxanthin possessing 
chiral centers, they can exist in many stereoisomeric forms. The trans form of xanthophylls 
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dominants in all foods over the cis form, however when examining processed foods a higher 
level of cis can be found than when examining fruits and vegetables, which may be due to 
isomerization during food processing (36). Isomerization is most impacted by thermal 
processing, however exposure to light and oxygen and even organic acid release through slicing 
and juicing can cause isomerization to occur (37). Within plants only one major stereoisomer of 
lutein, and one of zeaxanthin, is found due to stereospecific biosynthesis (38). Whether the 
carotenoid exists in the cis versus the trans form may impact its bioavailability in humans, 
however little research has investigated this for lutein and zeaxanthin.  
 As the macular pigment is entirely from dietary origin (39) it is important to establish 
which foods provide a good source of the nutrients, lutein and zeaxanthin, that accumulate here. 
Lutein and zeaxanthin come into the diet from plant material by direct means, or indirectly in the 
form of metabolites in animal products such as eggs. These carotenoids are concentrated in green 
leafy vegetables, many colored fruits and vegetables, and eggs (6, 40). Even though eggs have 
lower levels of lutein and zeaxanthin present, as shown in Table 1, the nutrients are more 
bioavailable in this form than from spinach or supplements (40). Table 1, showing lutein and 
zeaxanthin content in foods, was generated using the USDA National Nutrient Database for 
Standard Reference Release 28 (41). Most databases combine lutein and zeaxanthin, thus in 
Table 1 the third column displays their sum. Additionally, even though the database gave one 
number per food type, carotenoids need to be represented as a range of values as the carotenoid 
content of foods is highly variable. It can be impacted by many factors such as genotype, season, 
geography, cultivation variation, stage of maturity at harvest, and postharvest storage conditions 
(37). 
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Table 1. Lutein + Zeaxanthin Content of Selected Foods1 
Food Serving Lutein + Zeaxanthin (mg) 
Kale, frozen, cooked 1 cup 25.6 
Spinach, canned  1 cup 22.6 
Turnip greens, frozen, cooked 1 cup 19.5 
Chard, swiss, cooked 1 cup  19.3 
Collards, frozen, cooked 1 cup 18.5 
Mustard greens, cooked 1 cup 14.6 
Dandelion greens, raw 1 cup 7.5 
Peas and carrots, frozen, cooked 10 oz 4.3 
Zucchini, frozen, cooked 1 cup 4.2 
Eggs, whole  1 cup, sifted  0.7 
1Generated using the USDA National Nutrient Database for Standard Reference Release 28 (41) 
 Lutein is dominant over zeaxanthin in almost all foods, and ratios of 7:1 to 4:1 have been 
reported (33, 42). Indeed, lutein has been found to be the predominate xanthophyll in almost all 
fruits and vegetables (36).  Exceptions to lutein being the predominate xanthophyll are corn, 
some corn products, orange peppers, nectarines, and some varieties of potatoes where zeaxanthin 
is found in higher amounts than lutein (36, 43, 44). Daily mean intakes of combined lutein and 
zeaxanthin vary with age, sex and ethnicity between 0.4-4 mg per day depending on the 
population observed (45-49). Additionally, within a population the individual daily intakes vary 
greatly as demonstrated by high standard deviations reaching up to 2.45 mg/day in one study 
(47). While there are currently no DRIs for lutein and zeaxanthin, the recommended daily intakes 
based on food intake for a potential health benefit to be observed is 6mg (50). 
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Absorption and Accumulation 
 To start the digestion process the carotenoid must be released from the food matrix and 
incorporated into a mixed micelle, comprised of dietary lipids and bile acids (51). This 
incorporation facilitates absorption into the intestinal mucosal cells. The process of assimilating 
into the mucosal cell is still being investigated, however, there is evidence of passive diffusion 
(52) and facilitated uptake via class B scavenger receptors on the membrane brush border such as 
scavenger receptor class B type 1 (SR-B1) (53) and cluster of differentiation 36 (CD36) (54). 
Next, within the intestinal mucosa carotenoids are incorporated into chylomicrons, which are 
triglyceride-rich lipoproteins that allow them to be released into the lymphatic system (51). As 
the chylomicrons are in circulation, lipoprotein lipase acts on them hydrolyzing them into 
chylomicron remnants (CRs) and apolipoprotein E (apoE) is acquired. The CRs must achieve a 
size small enough to enter the space of Disse in the liver where absorption occurs (55). 
Additionally, apoE on the surface of the CR allows for the binding of the CR to hepatic low-
density lipoprotein (LDL) receptors and the subsequent endocytosis of the remnant particle into 
hepatocytes (56). Additional mechanisms for entry of CR into hepatocytes include acquiring 
additional apoE that is secreted free into the space, and then removal directly by the LDL 
receptor-related protein (LRP), or the CR may be sequestered in the space by either the binding 
of apoE to heparan sulfate proteoglycans and/or binding of apoB to hepatic lipase. The 
sequestered particles are then able to be furthered metabolized resulting in apoE enrichment that 
allows for the transfer of the particle to either an LDL or LRP receptor for hepatic uptake (56). 
Within the liver carotenoids can be accumulated or repackaged and released as components of 
very low density lipoprotein (VLDL). As time progresses the polar xanthophylls, lutein and 
zeaxanthin, become more equally distributed between LDL and HDL (57).   
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 The structure of carotenoids has some impact on their bioavailability. Due to their more 
polar nature, oxygenated carotenoids, the xanthophylls, have increased absorption over other 
hydrocarbon carotenoids. This polarity allows them to be incorporated into the outer portions of 
lipid micelles within the gastrointestinal tract, thus allowing for an easier uptake by the 
enterocyte membranes and ultimately chylomicrons, thus increasing their bioavailability (51). 
Indeed, the absorption of lutein was found to be five times higher than β-carotene (58).     
 In order for dietary carotenoids to be absorbed in the intestines they must be co-
consumed with a fat source. The amount of fat needed to aid in the absorption seems to be low at 
about 3-5 g per meal, but depends on the physicochemical characteristic of the carotenoid 
ingested, for example from a food matrix versus a presolubilized/ emulsified supplement (37, 
59). Additionally, from examining multiple studies it appears that higher levels of co-consumed 
lipids seem to enhance carotenoid absorption (37).   
 The actual uptake of lutein and zeaxanthin after ingestion is impacted by many other 
dietary factors besides just the fat amount in the meal. In addition to the amount of fat, the source 
of fat can impact bioavailability. Certain chain lengths and degrees of saturation of fatty acids 
have been shown to be more effective at stimulating chylomicron secretion than others (60). In 
one study, dietary fats rich in saturated fatty acids led to a higher bioavailability of lutein and 
zeaxanthin than did dietary fats high in monounsaturated fatty acids or polyunsaturated fatty 
acids (61). The food matrix is a major determinant of carotenoid bioavailability. Processing of 
carotenoids, via mechanical homogenization or heat treatment, tends to increase their 
bioavailability by potentially disrupting the cellular structure and releasing the carotenoids from 
the food matrix (62). Dietary fiber may inhibit carotenoid utilization. One study found a decrease 
of 40-74% in absorption of lutein depending on the type of fiber consumed (63). It has been 
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suggested that the intracellular location, chloroplasts in leaves versus chromoplasts in fruits and 
other parts of the plant, may result in different bioavailability of carotenoids with the former 
speculated to be harder to disrupt the food matrix (64, 65). Interactions between carotenoids may 
impact their absorption due to potential competition to be incorporated into the micelle or 
exchanging the compounds between lipoproteins (66). It has been demonstrated that when β-
carotene and lutein were ingested together the plasma levels of each were reduced compared to 
when they were ingested separately (67). 
 In addition to other dietary components consumed with carotenoids, personal 
characteristics may additionally impact absorption. Gastrointestinal malabsorption is a major 
issue that will severely limit carotenoid absorption, this could include intestinal parasites, 
steatorrhea, or fat malabsorption syndromes (68). Additionally, there are multiple genetic 
variations in genes that are involved in lipoprotein metabolism and lipid transfer that can affect 
the variability of plasma carotenoid concentrations in humans (69).  
Xanthophylls and the Macula 
 When examining where carotenoids accumulate in the body, it has been established that 
the highest concentration of xanthophylls is in the retina, comprised of lutein and zeaxanthin to 
the exclusion of all other dietary carotenoids. Despite lutein and zeaxanthin being accumulated 
throughout the eye tissue, they are only optically dense within and around the fovea (70). Lutein 
is the major carotenoid in the peripheral retina, whereas zeaxanthin becomes more and more 
dominant approaching the foveal center (47). Meso-zeaxanthin levels decrease with increasing 
radial distance from the fovea (71). The concentration of lutein and zeaxanthin in the retina is 
about 10,000-fold higher than in the blood (72). This concentration level has led to the concept 
of a specific binding protein for these xanthophylls (73). Relatively recent research has revealed 
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a SR-B1 dependent mechanism for uptake of xanthophylls, opposed to β-carotene, by the cells of 
the retina (74). Additional research has revealed other xanthophyll-binding proteins for the 
transfer of lutein and zeaxanthin from the blood to the retina (75) including the Pi isoform of 
glutathione S-transferase (GSTP1) that has a high affinity for zeaxanthin (73) and a member of a 
protein family collectively referred to as steroidogenic acute regulatory protein (StARD) as a 
lutein binding protein (76). Tubulin has been identified as a less specific, but higher capacity 
binding protein likely depositing carotenoids after specific uptake by other more specific binding 
proteins (77).  
 In addition to the retina, lutein and zeaxanthin accumulate at high amounts in other 
tissues. Another location where a large amount of carotenoids accumulate is in adipose tissue. 
Indeed, having excess fat mass may interfere with the ability of lutein to accumulate in the eye as 
the adipose tissue can serve as a ‘sink’ for lutein accumulation (78). Within the adipose tissue the 
accumulation of carotenoids is site specific, and higher concentrations are found in the abdomen 
than in the buttock or thighs (79).  CD36 has been reported to be involved in the uptake of lutein 
by the adipocytes and adipose tissue (80). The liver also has a large capacity for carotenoid 
accumulation; as described above the chylomicron remnant particles are taken up via endocytosis 
into hepatocytes and can remain there (56). Carotenoids accumulate at high levels in the skin. 
Measurements using resonance Raman spectroscopy have revealed a non-uniform distribution in 
the epidermis, with more accumulating where higher levels of sweat glands are present, as sweat 
carries carotenoids to the skin surface (81).  
Xanthophylls and the Brain 
 Finally, and perhaps of most importance to this current thesis, is the accumulation of 
lutein in the brain, where it is preferentially accumulated over all of the other dietary carotenoids 
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(19, 20).  In infants, lutein in the brain accounts for 59% of the total carotenoids despite it only 
constituting 12% of intake (19). Within the brain cortices of infants, lutein was found in 
significantly higher concentrations in the occipital cortex, hippocampus, frontal cortex, and 
prefrontal cortex, and was marginally higher in the auditory cortex (19). In the first study to 
investigate individual carotenoids and their contribution to the adult brain, the total concentration 
of carotenes was significantly less than the total concentration of xanthophyll carotenoids, which 
constituted 66-77% of the total carotenoids in both the frontal and occipital regions (82). 
Additionally, the total concentration of xanthophylls was significantly higher than carotenes in 
both the gray matter and in the white matter (82). In a subsequent adult study, xanthophylls 
accounted for 72% of the total carotenoids, of which lutein was found to account for 34% of 
carotenoids accumulated in the brain (20). Lutein in the adult brains was significantly higher 
than the other carotenoids even though β-carotene was the highest in the plasma (20).  
 MPOD may potentially be used as a biomarker to assess brain lutein and zeaxanthin 
status. In non-human primates, the only animals that possess a macula, lutein in the macula was 
positively related with lutein levels in the cerebellum, occipital cortex, and pons, while the 
relationship was marginally significant in the frontal cortex (18). Whereas, zeaxanthin in the 
macula was positively related to zeaxanthin levels in the cerebellum, frontal cortex, and pons and 
marginally significant for the occipital cortex. However, the relationships for zeaxanthin did not 
remain after adjustment for age, sex, and n-3 status, but the lutein relationships did (18). In 
humans, macular carotenoids in the retina were significantly related to their levels in the 
occipital cortex, but not in the hippocampus, and this relationship remained even after 
adjustment for age, sex, and cognitive status (83). The absence of the relationship in the 
hippocampus may be due to the small sample size (N=13) or potential pathological changes and 
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damage, as 7 of the 13 subjects had Alzheimer’s disease prior to death and the hippocampus is 
the first brain region affected early on in the pathogenesis of the disease. Additionally, this study 
was the first to demonstrate that meso-zeaxanthin was absent in the human brain tissue analyzed 
(83). The associations of lutein and zeaxanthin in the macular region and brain seem plausible 
given that the retina is part of the central nervous system. 
Functions  
 Within the retina there are two types of photoreceptors, rods and cones. Rods are 
responsible for vision at low light levels, do not mediate color vision and have a low spatial 
acuity, while cones are active at higher light levels, are capable of color vision and are 
responsible for high spatial acuity. Despite the small size of the macula within the retina, it 
constitutes a large proportion of the projection onto the visual cortex, and joined with the very 
high density of cone photoreceptors, this area of the retina has the highest visual acuity (84). 
Therefore, it is not surprising the amount of research devoted to this region of the retina. The 
macular pigment is mostly accumulated in the inner Henle fiber layer (85). This layer is 
composed of the photoreceptor axons that overlay the photoreceptors. Having this location 
allows the macular pigments to filter out blue light before reaching the delicate structures such as 
the photoreceptors, the retinal pigment epithelium and the underlying choriocapillaris (7). In 
individuals with the average macular pigment levels, 20 to 40% of light at 460nm can be 
absorbed, whereas in those with higher than normal macular pigment levels up to 90% of light 
may be absorbed (47).   
 Blue light is of a short wavelength, and these short wavelength lights have been shown to 
be particularly damaging to the retina (86). Lutein and zeaxanthin have been well established as 
blue light filters. Lutein and zeaxanthin have fully conjugated double bonds along their 
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backbones, whereas their rings are only partially in conjugation (33). The pattern of conjugation 
is important as it determines the light-absorbing properties of the carotenoid, and additionally it 
can influence the antioxidant activity of carotenoids (33). Lutein has an absorption maximum of 
445nm and zeaxanthin’s is 451nm, and as a result both carotenoids are efficiently absorbers of 
blue light (9, 87). Due to this high absorption, lutein and zeaxanthin are very effective at filtering 
the blue light prior to exposing delicate underlying tissues (9). It has been demonstrated that 
damage from acute exposure to blue light can be protected by the macular pigments (88). 
However, this acute exposure protection cannot yet be extrapolated to prove a protective role in 
low dose exposure to blue light.  
 Chromatic aberration occurs when light is not properly focused at the same point, which 
results in overlapping images and is commonly described as the occurrence of colored fringes 
and a loss of image sharpness. The presence of lutein and zeaxanthin, the yellow pigments in the 
macula, has been suggested to reduce the amount of blue fringes by absorbing some of the blue 
light (89, 90). However, it has not been well established the extent to which chromatic aberration 
may be limiting the acuity of the human eye.  
 A paper in 1920 discussed the possibility that the macular pigment could improve vision 
by improving contrast relations in the atmosphere (91). This idea was further developed by 
Wooten et al. (90) as a major new hypothesis, the visibility hypothesis, regarding how the 
macular pigment may improve visibility outdoors. This potential source of optical degradation is 
commonly overlooked when examining visual acuity and is sometimes referred to as blue haze. 
This blue haze is caused by small, suspended particles in the earth’s atmosphere that scatter short 
wavelength light more than other wavelengths resulting in a bluish veiling luminance. This haze 
can majorly impact how well and how far we can see targets outdoors. The macular pigment has 
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the ability to help improve the visual distortions caused by blue haze by absorbing the short 
wavelengths produced and allowing for increased contrast (90).  
 In addition to filtering out blue light, carotenoids have antioxidant properties. Lutein and 
zeaxanthin are effective at quenching reactive oxygen species (ROS). This has been 
demonstrated as oxidized byproducts of lutein and zeaxanthin have been identified within the 
human retina, which is indicative of a function as retinal antioxidants (11). Among ROS, 
carotenoids are the most effective at scavenging peroxyl radicals, which are generated during 
lipid peroxidation (33). Due to their lipophilic nature and scavenging peroxyl radicals, 
carotenoids are proposed to play an important role in protecting cellular membranes from 
oxidative damage (92). In addition to peroxyl radicals, carotenoids are efficient at physically 
quenching singlet oxygen (93), and this physically quenching by direct energy transfer allows for 
them to remain intact and be reused many times in quenching cycles (33, 93). Additionally, 
higher concentrations of zeaxanthin resulted in lower singlet oxygen quenching, suggesting an 
optimal concentration for carotenoids, specifically zeaxanthin, and that extra is not necessary 
beneficial (93).  This concept was again demonstrated when skin fibroblasts were exposed to 
UVB light and an optimum concentration of lutein was found for protection. When concentration 
levels of lutein were below optimum less protection was found, whereas at higher levels 
prooxidant effects were observed (94). 
 Lutein and zeaxanthin have been shown to be more stable under photo-oxidative 
conditions than lycopene and β-carotene; when exposed to UV light in the presence of Rose 
Bengal (a singlet oxygen generator), when in the presence of a peroxyl radical initiator, when 
‘bleached’ with hypochloric acid (NaOCL), and when exposed to natural sunlight, lutein and 
zeaxanthin were more resistant to degradation than lycopene and β-carotene (10). This slower 
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degradation under photo-oxidative states may be indicative of why the macular carotenoids 
accumulate in the retina over lycopene and β-carotene.   
 Due to their physicochemical properties, it is likely that the main task of carotenoids in 
the macula is to prevent damage from photo-oxidation. The functions described above point to 
the accomplishment of this in two main ways, blue light filtration and their antioxidant 
properties. Indeed, UV light exposure has been related to cataract formation and retinal 
degeneration (95). Additionally, there is increasing evidence that greater intake of the macular 
carotenoids, lutein and zeaxanthin, is inversely related with risk for age related macular 
degeneration (50, 96), which is the leading cause of blindness in developed countries (97).   
 Lastly, of most relevance to this thesis, is the potential contributions lutein and 
zeaxanthin may make to cognitive function. Many of the benefits observed in the eye may 
translate to the brain. Specifically, it is currently believed that carotenoids mediate cognitive 
function by mitigation of neuroinflammation (98). High plasma total carotenoid concentrations 
have been associated with reduced plasma interleukin-6 (IL-6) levels; IL-6 is an interleukin that 
can act as a pro-inflammatory cytokine or can have positive modulatory effects in the central 
nervous system likely dependent on its level of expression (98). Further, lutein may inhibit 
cytokine production via suppressing ROS stimulated nuclear factor kappa beta (NF-κβ) 
activation (99).  
  Lutein’s antioxidant properties are of importance in the brain as it is especially 
vulnerable to free radical damage due to its relatively low antioxidant content, high 
polyunsaturated fatty acid (PUFA) concentration, and high metabolic activity (100). Macular 
xanthophylls, lutein and zeaxanthin, were found to be about 14 times more concentrated in 
domains where docosahexaenoic acid (DHA), a polyunsaturated fatty acid, is present versus 
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domains where cholesterol and saturated lipids are present (101). This preferential location in 
domains formed from unsaturated lipids is ideal if they are to act as a lipid antioxidant.  Also it is 
possible that these antioxidant and anti-inflammatory properties are particularly beneficial during 
childhood, since this period is characterized by extensive changes in both structure and function 
of the brain (102, 103).  Furthermore, there may be a neuroprotective role of lutein in early 
neural development as the relative contribution of lutein to the total carotenoids in infant brains 
is almost two-fold greater than in adults, 59% versus 34% (19, 20).   
 Lutein and zeaxanthin have polar groups at each end that allow them to span membranes 
in lipid bilayers, while their non-polar counterparts, carotenes, are oriented rather randomly. This 
spanning configuration allows a nearly perpendicular orientation, enhancing their stability in 
membranes (104). Combining this property with their high solubility in membranes can strongly 
influence other membrane properties, such as fluidity, ion exchange, and oxygen diffusion (104), 
and may be contributing to their enhancement of interneuronal communication through gap 
junctions (105). 
 Future studies should investigate specific brain regions and membrane types in which 
lutein and zeaxanthin accumulate to better understand its functions as membrane composition 
varies among cell types and cellular compartments (106). As elaborated upon in a recent review 
by Erdman et al. (107), mitochondrial, nuclear, myelin, and neuronal plasma membranes have 
unique functions, many of which can determine cell viability. Determining which membrane 
types lutein and zeaxanthin accumulate in may give clues to its potential functions. As stated in 
the review, if found in neuronal plasma membranes it may influence cell survival signal 
transduction, in the mitochondria it may protect this organelle from damage, in the nucleus it 
may help with gene regulation and DNA damage that affect cell viability, and in myelin it may 
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be functioning to influence structural integrity and maintain proper communication between the 
neurons (107). 
Dietary Factors and their Relationships with Cognition in Children 
Overall diet quality 
 To date, most studies investigating nutrition and academic achievement have focused on 
hunger, malnutrition, micronutrient deficiency, and breakfast consumption (108). Few studies 
have focused on well-nourished children and the impact of nutrition on their academic 
achievement. One study did investigate overall diet quality and academic achievement in 5th 
graders from Nova Scotia, Canada (N=5,200), and found overall diet quality to be important to 
academic achievement, above and beyond socioeconomic factors (27). They utilized the Harvard 
Youth/ Adolescent Food Frequency Questionnaire (YAQ) and calculated the Diet Quality Index-
International (DQI-I) and the Healthy Eating Index (HEI) for composite measures of diet quality 
(109, 110). However, their academic measures were lackluster, as they used a dichotomous 
variable to measure academic achievement based on whether the children passed or failed one of 
two tests, a reading and writing assessment. Failing either test, or both tests, resulted in being 
rated as poor academic performance, while passing both was considered good academic 
performance (27). Therefore studies with better measures of academic achievement need to be 
implanted to expand upon their findings. 
Fruit and Vegetable Intake 
 Within overall diet quality a Canadian study found that students with an increased intake 
of fruits and vegetables, known to be good sources of carotenoids, was positively associated with 
academic performance (27). This study did not account for health markers that may improve 
cognitive function, such as weight status and fitness, (111) while this thesis does account for 
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these markers. Additional studies that have accounted for health makers have shown that intake 
of dietary fibers, nutrients abundantly found in fruits and vegetables, is positively associated with 
cognitive control (112). An alternative explanation may be that high dietary fiber is an index of 
healthy eating, and therefore these results may reflect a more general benefit of diet quality on 
cognition.  
MPOD  
History 
 The first description of the macular yellow spot was in 1782 (113), and this was followed 
by the first literature review in 1798 (114). Macular pigment was originally described to contain 
xanthophylls, possibly lutein, by Wald in 1945 (8). Wald showed that these xanthophylls were 
concentrated within the macula. Additionally, Wald proved that this yellow pigment absorbed 
wavelengths between 430 and 490nm with a maximum absorption at 465nm. It was not until 
1985 that the pigments in the eye were further identified as lutein and zeaxanthin (32). Later in 
1993 an additional carotenoid was identified in the eye as meso-zeaxanthin (4). No significant 
amount of meso-zeaxanthin has been found in the diet, and it is not detectable in significant 
amounts in other human tissues or blood (4, 115); it has been proposed that this isomer is formed 
in the ocular tissue due to conversion of lutein (115).  
MPOD relation to Diet 
 While the relationship between dietary intake and MPOD has been shown to be 
significant and positive in three studies, this result is not consistent within the literature (29). 
Lutein and zeaxanthin, the dietary carotenoids composing the macular pigment, can be measured 
by food frequency questionnaires, food records, and food recalls, but studies with these measures 
need to be interpreted with caution for a several reasons. These studies may introduce subject 
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recall bias, there could be possible digestive and absorptive idiosyncrasies among subjects, and 
using different sources of carotenoid data by investigators may introduce inconsistencies 
between studies (29).  Additionally, subjects vary greatly in their ability to accumulate dietary 
lutein and zeaxanthin in the macula as macular pigment (30). Thus, it is of importance to be able 
to make reliable measures in neural tissues, if an aim of a study will examine cognition. 
Heterochromatic flicker photometry (HFP) has been demonstrated to be a reliable non-invasive 
measure of retinal lutein, a surrogate measure of brain concentrations of lutein (18), in both 
adults and children (116, 117).  Thus, the use of the moderately reliable technique of 
heterochromatic flicker photometry in preadolescent children (117) is utilized in this current 
thesis to mitigate the potential issues introduced by dietary recall by providing an objective 
measure of MPOD.  
MPOD relation to Cognition 
 Both MPOD and dietary lutein supplementation have been associated with better 
cognitive function among older adults (22-24). Within the study by Vishwanathan et al., six of 
the eight measured cognitive functions in healthy older adults with normal cognitive function 
were significantly correlated with MPOD measured via HFP. These included measures of global 
cognition, verbal learning and fluency, recall, processing speed, and perceptual speed after 
adjusting for age, BMI, education and sex (22). Another study again showed that lower MPOD 
measured via HFP was significantly associated with worse performance on tests of global 
cognitive function and processing speed; additionally lower MPOD was associated with worse 
executive function and prospective memory (23).  In the Georgia Centenarian Study brain 
samples collected at postmortem that contained higher concentrations of lutein and zeaxanthin 
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were associated with better cognitive function at the time of death (20). Finally, lutein 
supplementation has been shown to improve verbal fluency among older women (24).    
 To date, MPOD assessments are limited in preadolescents, and since lutein is the 
predominant carotenoid in the brain starting in early life (19), this is of concern. The scarcity of 
MPOD data in children has resulted in limited knowledge of the importance of dietary or brain 
lutein for optimal cognitive function and brain development (118, 119). Accordingly, the present 
thesis seeks to utilize HFP to measure MPOD and investigate how it relates to academic 
achievement in preadolescents.  
Hypotheses 
 Due to the preferential accumulation of lutein in the brain over other carotenoids, and the 
beneficial functions of lutein and zeaxanthin, it was hypothesized that higher MPOD would be 
associated with superior performance on standardized academic achievement tests among a 
sample of preadolescent children. Dietary intake of lutein and zeaxanthin and MPOD measures 
were hypothesized to be positively correlated. Furthermore, for the subsample with diet data, it 
was hypothesized that the relationship of MPOD to academic performance would be mediated, in 
part, by diet.  
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Chapter 3 – METHODOLOGY 
 The present thesis applies the moderately reliable approach of measuring MPOD in 
preadolescent children by use of heterochromatic flicker photometry (117) and relate it to 
cognitive outcomes. Additionally, this thesis investigates how dietary intake of lutein and 
zeaxanthin, measured via 3-day food records, relates to MPOD in children and how diet may 
mediate the relationships of MPOD to academic measures Accordingly, the research design and 
methods are described below.  
Participants 
 Preadolescent children between the ages of 8 and 10 years from the East-Central Illinois 
community were recruited to participate in this study. Participants were excluded due to the 
presence of neurological disorders, physical disabilities, and psychoactive medication status. All 
participants had normal or corrected-to-normal vision. All participants provided written assent 
and their legal guardians provided written informed consent in accordance with the ethical 
standards and regulations of the Institutional Review Board (IRB) of the University of Illinois at 
Urbana-Champaign (Institutional Review Board number 12321).  
 This study utilized children from 2 different waves of the FITKids randomized controlled 
trial, an on-going physical activity intervention trail. All children (n = 49) from the 2015-2016 
FITKids enrollment were included at their baseline measurement, prior to any intervention.  
Seven children from the 2014-2015 FITKids enrollment were included in the analysis at post 
intervention. These 7 children had the same examiners as the 2015-2016 FITKids, thus reducing 
variability stemming from the use of more than two examiners (117).  
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Procedure 
 All testing protocols were identical at baseline and post-intervention testing, thus including 
children from both time points should not be a confounding variable. Testing occurred across 
two separate days. On the first visit to the laboratory participants completed informed assent/ 
consent, the Woodcock Johnson Tests of Cognitive Abilities to estimate intelligent quotient (IQ) 
(120), the Kaufman Test of Academic and Educational Achievement II (KTEA II) to assess 
scholastic achievement (121), had their height and weight measured, and completed a maximal 
oxygen consumption test (VO2max) to assess aerobic fitness (122). All cognitive testing took 
place prior to the cardiorespiratory fitness assessment to avoid any confounding effects of acute 
physical activity on cognitive performance (123). Concurrently, their legal guardian completed a 
preliminary screening, demographic and health history questionnaire, and pubertal timing scale 
(on behalf of their child) via the Tanner Staging Scales (124). From the information the parents 
provided, socioeconomic status (SES) was determined by creating a trichotomous index based on 
participation in a school meal-assistance program, maternal and paternal education levels, and 
the number of parents with full time employment. Before leaving the appointment participants 
were given food records to complete at home for three days, 2 week days and 1 weekend day, 
before their return to the lab. On the second visit, participants were fitted with an EEG cap and 
completed cognitive testing in a quiet chamber, and they completed an assessment of body 
composition. At both visits participants completed the MPOD assessment, and the average of the 
two values was used throughout this thesis. 
MPOD 
MPOD was measured using customized HFP (cHFP) and a macular densitometer 
(Macular Metrics Corporation, Rehoboth, MA USA) that was identical to a version described by 
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Wooten et al. (125) except that it did not allow for an assessment of the entire spatial profile. 
This procedure has been described previously (126). However, this study utilized a slightly 
varied form of the procedure typically described in adult studies. Unimpaired adults receive 
instruction from a trained examiner, and then they manipulate the radiance of the short-wave 
component of the test stimulus themselves (method of adjustment) to produce a null flicker zone. 
In this study, the psychophysical technique was modified as described previously by Renzi et al. 
(127) for older adults with mild cognitive impairment. Briefly, instead of manipulating the 
radiance of the short-wave component themselves to find thresholds, the examiner manipulated 
the radiance of the short-wave component of the test stimulus while using simplified instructions 
also known as the method of limits. After the null zone was found via the method of limits, the 
method of constant stimuli was used to further narrow the range of the null zone.   
The MPOD assessment started by determining a critical flicker frequency, which 
facilitates subject performance and reduces measurement error (126).  An algorithm was 
established for each subsequent test to help the examiner know where to start the flicker 
frequency (126). Next, the participant views a disk that alternates between a blue wavelength 
(that is absorbed by the MP) and a green wavelength (which is not observed by the MP). This is 
done at two locations in the eye. First at a central (foveal) location, and then at a peripheral 
(parafoveal) location (7° eccentricity).  The participant informs the examiner when they perceive 
the blinking to slow down to a stop, and thus a null flicker zone has been identified. If for either 
the foveal or parafoveal measurements the participant is unable to see a null flicker zone, or their 
null flicker zone was large, then the examiner adjusted the flicker frequency accordingly.  
At both the foveal and parafoveal points the radiance of the blue light is adjusted by the 
examiner until a null flicker is reached. The difference between the required radiance at the 
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foveal and parafoveal points reflects the participants MPOD (23). This is due to the MP being at 
its highest density at the foveal, while at the parafoveal the MP is negligible (85). The calculation 
of MPOD is as follows: 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 =  − log10 �𝑅𝑅𝑓𝑓𝑅𝑅𝑝𝑝� where Rf is the radiance of the blue light needed 
for flicker null at the foveal location and Rp is the radiance for a flicker null at the reference 
location in the parafoveal. 
Body Composition Assessment 
 Participants height and weight were measured in stocking feet using a stadiometer and a 
Tanita WB-300 Plus digital scale (Tanita, Tokoyo, Japan), respectively. The mean of three 
measurements of height and weight were used for analyses. BMI was calculated by dividing 
body mass (kg) by height (m) squared ((kg)/ht(m)2). Next, fat and muscle mass was measured 
using dual-energy X-ray absorptiometry (DXA) with a Hologic Discovery A bone densitometer 
(software version 12.7.3;Hologic, Bedford, MA). 
Academic Achievement Assessment 
Participants were administered the Kaufman Test of Academic and Educational 
Achievement II (KTEA II) (121). The comprehensive form was administered to determine a 
comprehensive achievement score. Academic outcomes included composite scores on math 
(math concepts and application and math computation subtests), reading (letter and word 
recognition and reading comprehension subtests), reading fluency (word recognition fluency and 
decoding fluency subtests), written language (written expression and spelling subtests), and the 
comprehensive achievement scores (reading composite, math composite, written expression 
subtest, and listening comprehension subtest). All scores reported herein are standard scores 
generated by using the age norms standard scores produced by KTEA II comprehensive norms 
(128).  
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 The math concepts and application subtest was an 88-item subtest, which began with 
easier items that included basic math concepts such as comparing numbers and rounding 
numbers, and progressed to more difficult problems that required algebra, calculus, and 
trigonometry. The math computation subtest consisted of 72 items and asked participants to add, 
subtract, multiply, and divide whole numbers and fractions. Problems progressed in difficulty by 
involving exponents, decimals, negatives, and unknown variables. Participants had access to 
pencil and paper but were not allowed to use a calculator for the math subtests.  The letter and 
word recognition subtest had participants pronounce words of gradually increasing difficulty. 
The reading comprehension subtest began with the participant reading a word and pointing to its 
corresponding picture. It progressed in difficulty by having the student perform the action of the 
word, and then answer literal or inferential questions about passages they read. For the word 
recognition fluency subtest the participant read isolated words as quickly as possible for one 
minute, and in the decoding fluency subtest they pronounced as many nonsense words as 
possible in one minute. For the written expression subtest the participant completed writing tasks 
in the context of an age-appropriate storybook format. In the spelling subtest the participant 
wrote words the examiner dictated from a steeply graded word list. In the listening 
comprehension subtest the participant listened to passages played from a CD and then orally 
responded to questions asked by the examiner (128).  
Diet assessment 
 Three-day food records, with 2 week days and 1 weekend day, were used to determine 
dietary intake of lutein and zeaxanthin. The records were completed by the child with assistance 
from the parent. Both child and parent received instructions on how to correctly fill out the food 
records. Additionally, the records contained written instructions for recording food intake, 
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including portion size examples, how to describe food preparation methods, added fats, brand 
names, and ingredients of mixed dishes and recipes. The three days of intake were entered into 
Nutrition Data System for Research (NDSR 2014; Nutrition Coordinating Center, Minneapolis, 
MN, USA) software by trained staff. To investigate nutrient-level intakes the intake properties 
file from NDSR was utilized. The three days of intake were averaged together, and subsequently, 
these averages are used in the data analyses.  
Statistical Analysis 
  A bivariate correlation was performed between dietary intake of lutein and zeaxanthin 
and MPOD. Next, bivariate correlations between MPOD, and lutein and zeaxanthin, with the 
academic composite scores were calculated. 
Following correlational analyses, the relationship between MPOD and academic 
performance was examined using multiple hierarchical linear regression analyses. First, 
confounding demographic and health variables determined via the bivariate correlations were 
included in step 1 of the final regression model predicting academic performance. Additionally, 
variables of a higher accuracy in their measurement of interest were chosen to be included in the 
modeling at step 1. For example, if both BMI and whole body percent fat correlated with the 
academic measures, then whole body percent fat would be included because it a direct measure 
of fat mass. Further, in instances where factors known to be related to sex, such as whole body 
percent fat or VO2max, are significantly related but sex is not, then independent t-tests were 
performed to determine whether these measures varied between sexes. If cases where a 
difference was observed between sexes in the independent t-test, then sex was entered into step 1 
of the model. Following adjustment of step 1 variables, MPOD outcomes were included in step 2 
of the regression model.  The change in variance of performance explained by MPOD on each 
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academic achievement variable in step 2 was examined. For the subsample regressions, step 1 
remained the same as in the full sample, then in step 2 dietary intake of lutein and zeaxanthin 
was included, and in step 3 MPOD was added. The change in variance of performance explained 
by MPOD on each academic achievement variable in step 3 was examined to see how diet may 
mediate the relationships between MPOD and academics. The α level was set at 0.05 and SPSS 
22 was used to perform all statistical analyses.  
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Chapter 4 – RESULTS 
Participant Demographic Information 
Table 2 presents participant characteristics, KTEA II academic performance standard 
scores of participants, MPOD, and dietary intake of lutein and zeaxanthin. To determine the 
relationship between dietary measure of lutein and zeaxanthin with the psychophysical measure 
(i.e., MPOD measured via HFP) a correlation between the two was performed. Figure 1 
demonstrates this relationship.   
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Table 2. Participant characteristics, academic performance, MPOD, and dietary lutein and 
zeaxanthin intake among preadolescent children1  
Characteristic  Full Sample  Males Females 
Age (y) 8.8 ± 0.1 8.7 ±0.2 8.8 ± 0.1 
Sex [n (%)]     
     Male 17 (30) - - 
     Female  39 (70) - - 
IQ 112.8 ± 1.7 115.6 ± 3.1 111.5 ± 2.0 
VO
2
 max (mL*kg-1*min-1) 43.0 ± 1.1 48.1 ± 2.1 40.8 ± 1.1 
Fat Free Mass VO
2
 max (mL*kgFFM-1*min-1) 61.9 ± 1.0 64.9 ±  1.9 60.6 ± 1.1 
BMI (kg/m2) 18.7 ± 0.4 18.1 ± 1.0 18.9 ± 0.46 
BMI-for-age percentile2 70.9 ± 3.5 66.0 ± 6.1 73.0 ± 4.2 
     Underweight, BMI percentile < 5 [n (%)] 0 (0) 0 (0)  
     Normal weight, BMI percentile ≤5 and <84.9 [n (%)] 32 (57) 12 (71) 20 (51) 
     Overweight, BMI percentile ≤85 and <94.9 [n (%)] 14 (25) 3 (18) 11 (28) 
     Obese, BMI percentile > 95 [n (%)] 10 (18) 2 (11) 8 (21) 
Whole Body % Fat (%) 31.3 ± 0.9 27.7 ± 1.5 32.8 ± 1.0 
SES [n (%)]    
     Low  22 (39)  5 (29) 17 (44) 
     Middle 19 (34) 6 (35) 13 (33) 
     High 15 (27) 6 (35) 9 (23) 
Pubertal Timing [n (%)]    
     Stage 1-2  51 (91) 17 (100) 34 (91) 
     Stage 2-3  5 (9) 0 (0) 5 (9) 
Math Composite  108.3 ± 2.3 112.4 ± 4.4 106.6 ± 2.6 
Reading Composite 111.5 ± 2.1 114.5 ± 4.0 110.2 ± 2.4 
Reading Fluency Composite 111.1 ± 2.1 113.4 ± 3.9 110.2 ± 2.5 
Written Language Composite 106.6 ± 2.5 105.3 ± 4.8 107.6 ± 3.0 
Achievement Composite 109.5 ± 2.2 112.5 ± 4.0 108.1 ± 2.7 
MPOD 0.64 ± 0.03 0.68 ± 0.05 0.62 ± 0.03 
Lutein/ Zeaxanthin (mcg)3 806.6 ± 63.0 1117.9 ± 177.2 728.7 ± 58.2 
1Values are means ± SEM n = 56. IQ, intelligence quotient; VO
2
 max, maximal oxygen uptake; SES, 
socioeconomic status; MPOD, macular pigment optical density. 
2Determined by the 2000 Centers for Disease Control and Prevention BMI-for-age growth charts  
3n = 35 (females: n = 28 and males: n = 7); n = 18 did not return food records and n = 3 were cut out due 
to being outliers  
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Figure 1. Illustration of the correlation between MPOD and lutein and zeaxanthin intake (n = 35; n = 18 
did not return food records and n = 3 were cut out due to being outliers) 
 
Bivariate correlations 
Bivariate correlations between the achievement composite score and the demographic 
measures were performed. These correlations revealed that IQ (r = 0.62, P < 0.01), VO2max (r = 
0.33, P = 0.01), and fat free mass VO2max (r = 0.26, P = 0.05) were positively correlated with 
the achievement composite score. BMI (r = -0.37, P < 0.01) and whole body percent fat (r = -
0.30, P = 0.03) were negatively correlated with the achievement composite score. Age, sex, 
pubertal timing, and SES did not significantly correlate with the achievement composite score (r 
≤ │0.21│, P ≥ 0.13). Bivariate correlations between MPOD with the KTEA II academic 
composite scores as well as bivariate correlations between lutein and zeaxanthin with the KTEA 
II academic composite scores are shown in Table 3.  
Table 3. Bivariate correlations between KTEA II performance and lutein and zeaxanthin intake 
among preadolescent children1 
 Carotenoid Achievement Reading  Math 
Written 
Language 
Reading 
Fluency 
MPOD 0.40** 0.28* 0.35** 0.41** 0.22 
Lutein and Zeaxanthin2 0.29 0.16 0.14 0.53** 0.23 
 1All are academic achievement composite standard scores based on age norms. *P < 0.05 **P < 
0.01(two-tailed) 
2n = 35; n = 18 did not return food records and n = 3 were cut out due to being outliers 
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 Bivariate correlations between MPOD and demographics revealed that age, sex, pubertal 
timing, SES, IQ, BMI, whole body percent fat, VO2max, and fat free mass VO2max had no 
significant correlations with MPOD (r ≤ │0.22│, P ≥ 0.10). Bivariate correlations between 
lutein and zeaxanthin intake and demographics revealed that age, pubertal timing, SES, IQ, BMI, 
whole body percent fat, VO2max, and fat free mass VO2max had no significant correlations with 
lutein and zeaxanthin intake (r ≤ │0.28│, P ≥ 0.10). However, sex did have a significant 
correlation (r = 0.42, P = 0.01) with lutein and zeaxanthin intake.  
Hierarchical Regressions 
The stepwise hierarchical regression models are summarized in Table 4 for the 
composite scores and Table 5 summarizes the decomposition of their subtests. As IQ, BMI, 
whole body percent fat, VO2max, and fat free mass VO2max were significantly correlated with 
the achievement composite score, these factors were considered for entry into step 1 of the 
model. Sex was entered, despite not being significantly correlated with the academic composite, 
due to whole body percent fat and fat free mass VO2max differing between genders in 
independent t-tests [whole body percent fat was significantly different for girls (M = 32.8 SE = 
1.0) and boys (M = 27.7, SE = 1.5), t(54) = 2.9, p = 0.01; and fat free mass VO2max was 
significantly different for girls (M = 60.5, SE = 1.1) and boys (M = 64.9, SE = 1.9), t(54) = -2.1, 
p = 0.04]. Therefore, sex, IQ, whole body percent fat, and fat free mass VO2max were entered in 
step 1 of the regressions shown in Table 4 and Table 5.  Subsequent addition of MPOD in step 2 
was conducted to determine the contribution to the academic measures following step 1 
adjustments. The addition of MPOD did not statistically improve the ΔR2 for the reading or 
reading fluency composite scores or any of their subtests (letter and word recognition, reading 
comprehension, word recognition fluency, and decoding fluency), nor did it improve the ΔR2 for 
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the listening comprehension subtest. However, the addition of MPOD resulted in a significant 
improvement in the model ΔR2 at step 2 for the achievement composite standard scores (ΔR2 
=0.10, P = 0.002), math composite standard scores (ΔR2 = 0.07, P = 0.02), and written language 
composite standard scores (ΔR2 = 0.15, P = 0.001), as well as the math subtests: math concepts 
(ΔR2 = 0.05, P = 0.04), and math computation (ΔR2 = 0.09, P = 0.02), and the written language 
subtests: written expression (ΔR2 = 0.11, P = 0.008), and spelling (ΔR2 = 0.13, P = 0.004). 
 
Table 4. Summary of regression analyses predicting academic achievement composite standard 
scores1 
 
 
Achievement  Reading Math  
Written 
Language  
Reading 
Fluency 
Step and Variable  β ΔR
2
 β ΔR
2
 β ΔR
2
 β ΔR
2
 β ΔR
2
 
Step 1  
 
0.43* 
 
0.40* 
 
0.32* 
 
0.23* 
 
0.29* 
Sex -0.04 
 
-0.02 
 
0.00 
 
-0.12 
 
-0.01 
 IQ 0.60* 
 
0.57* 
 
0.47* 
 
0.47* 
 
0.52* 
 Whole body % fat -0.02 
 
0.04 
 
-0.04 
 
-0.04 
 
0.10 
 Fat Free Mass VO2 0.22 
 
0.29* 
 
0.24 
 
-0.04 
 
0.22 
 Step 2 
 
0.10* 
 
0.04 
 
0.07* 
 
0.15* 
 
0.02 
Average MPOD 0.32* 
 
0.20 
 
0.27* 
 
0.40* 
 
0.16 
 1 *P < 0.05. IQ, Intelligence quotient. 
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Table 5. Summary of regression analyses predicting academic achievement subtest standard scores1 
Composite 
Test Reading  Math Written Language  Reading Fluency Subtest  
Subtest 
Letter and  
Word Recognition  
Reading  
Comprehension  
Math  
Concepts 
Math 
Computation 
Written 
Expression Spelling 
Word Recognition  
Fluency  
Decoding 
 Fluency 
Listening 
Comprehension 
Step and 
Variable β ΔR2 β ΔR2 β ΔR2 β ΔR2 β ΔR2 β ΔR2 β ΔR2 β ΔR2 β ΔR2 
Step 1 
 
0.31* 
 
0.33* 
 
0.38* 
 
0.20* 
 
0.16 
 
0.19* 
 
0.25* 
 
0.24* 
 
0.29* 
Sex 0.07 
 
-0.09 
 
0.04 
 
-0.02 
 
-0.10 
 
-0.10 
 
-0.07 
 
0.06 
 
0.01 
 IQ 0.47* 
 
0.54* 
 
0.56* 
 
0.30* 
 
0.37* 
 
0.45* 
 
0.49* 
 
0.45* 
 
0.47* 
 Whole 
body % fat 0.02 
 
0.05 
 
-0.03 
 
-0.04 
 
-0.07 
 
0.04 
 
0.14 
 
0.04 
 
0.04 
 Fat Free 
VO2 0.25* 
 
0.26* 
 
0.15 
 
0.29* 
 
-0.09 
 
0.05 
 
0.24 
 
0.17 
 
0.26* 
 Step 2 
 
0.02 
 
0.04 
 
0.05* 
 
0.09* 
 
0.11* 
 
0.13* 
 
0.01 
 
0.03 
 
0.00 
Average 
MPOD 0.14 
 
0.21 
 
0.24* 
 
0.30* 
 
0.35* 
 
0.36* 
 
0.12 
 
0.18 
 
0.03 
 1 *P < 0.05. IQ, Intelligence quotient. 
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Hierarchical Regressions in the Diet Subsample 
The stepwise hierarchical regression models in the subsample providing diet data, n=35, 
are summarized in Table 6 for the academic composite scores. Sex, IQ, whole body percent fat, 
and fat free mass VO2max were entered in step 1 of the regressions. Subsequent addition of 
lutein and zeaxanthin intake in step 2 was conducted to determine the contribution to the 
academic measures following step 1 adjustments. The addition of lutein and zeaxanthin only 
improved the ΔR2 for the written language composite score (ΔR2 = 0.24, P < 0.01.), with a trend 
for the overall academic achievement composite (ΔR2 = 0.06, P = 0.09).  With the addition of 
MPOD in step 3 of the model, significant improvements in the model ΔR2 were observed for the 
achievement composite standard scores (ΔR2 = 0.20, P < 0.01), reading composite standard 
scores (ΔR2 = 0.10, P = 0.04), math composite standard scores (ΔR2 = 0.20, P < 0.01), and 
written language composite standard scores (ΔR2 = 0.10, P = 0.02), but not for reading fluency 
composite scores. 
 
Table 6. Summary of regression analyses predicting academic achievement composite standard 
scores in a subsample of children that returned dietary records1,2 
 
 
Achievement  Reading Math  
Written 
Language  
Reading 
Fluency 
Step and Variable  Β ΔR
2
 β ΔR
2
 β ΔR
2
 β ΔR
2
 β ΔR
2
 
Step 1  
 
0.42* 
 
0.32* 
 
0.38* 
 
0.22 
 
0.31* 
Sex 0.01 
 
0.06 
 
-0.04 
 
0.05 
 
0.07 
 IQ 0.56* 
 
0.50* 
 
0.43* 
 
0.40* 
 
0.44* 
 Whole body % fat -0.10 
 
0.05 
 
-0.16 
 
-0.11 
 
0.13 
 Fat Free Mass 
VO2 0.15 
 
0.17 
 
0.28t 
 
-0.08 
 
0.27 
 Step 2 
 
0.06t 
 
0.01 
 
0.01 
 
0.24* 
 
0.05 
L and Z 0.27t 
 
0.14 
 
0.11 
 
0.56* 
 
0.26 
 Step 3  0.20*  0.10*  0.20*  0.10*  0.02 
Average MPOD 0.50*  0.34*  0.50*  0.35*  0.17  
1 *P < 0.05. tP < 0.10. IQ, Intelligence quotient. L and Z, Lutein and Zeaxanthin intake. 
2n = 35; n = 18 did not return food records and n = 3 were cut out due to being outliers 
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CHAPTER 5 – DISCUSSION 
 The aim of the present thesis was to evaluate the relationships between dietary lutein and 
zeaxanthin intake, MPOD, and academic achievement measures among preadolescent children. 
The major finding was that children with higher MPOD values have superior performance on 
academic measures, particularly in math and written language. Given that MPOD was positively 
related to academic outcomes, even after the adjustment of sex, IQ, whole body percent fat, and 
fat free mass VO2max, points to the importance of the habitual intake of lutein and zeaxanthin, as 
indirectly indicated by MPOD, for improved academic performance. This finding is important 
because macular lutein is modifiable and can be manipulated by dietary intake in most of the 
population (30).   
 The results of this thesis demonstrate that the associations of the various academic 
composite measures with MPOD were fairly consistent, whereas associations between academics 
and self-reported dietary intake of lutein and zeaxanthin were not as consistent. MPOD has been 
shown to be a stable measure of carotenoids embedded in the retina and has been demonstrated 
to be a better representation of long-term intake of lutein and zeaxanthin than serum (22). This 
may explain why MPOD was more consistent with academic measures than self-reported dietary 
intake of lutein and zeaxanthin. In an adult study, MPOD was related to six out of the eight 
cognitive measures, whereas serum concentrations of lutein and zeaxanthin were only positively 
related to one of the eight (22), thus demonstrating similar relationships to MPOD and measures 
that reflect recent nutritional intake of lutein and zeaxanthin (29) as our findings. Other factors 
contributing to the inconsistency of self-report diet records to cognitive measures is that their use 
may introduce subject recall bias, there could be possible digestive and absorptive idiosyncrasies 
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among subjects, and using different sources of carotenoid data by investigators may introduce 
inconsistencies between studies (29).   
 A positive relationship between dietary intake and MPOD was found in this sample. Such 
a finding is congruent with some, but not all, adult studies (29). This lack of consensus across 
studies is interesting as many factors impact the absorption of lutein and zeaxanthin into the 
blood (51). Further, some tissues may compete for the uptake of lutein and zeaxanthin, which 
may interfere with this relationship (78, 81). As this finding was observed in a small subset of 
the entire sample, those that returned diet records (n = 35), further study in larger samples of 
children is warranted to determine the robustness of this relationship.  Contrary to our 
hypothesis, within the subsample, diet did not mediate the relationships of MPOD to academics. 
While this analysis was completed in a smaller sample size (n = 35 versus n = 56), it brings 
about the speculation that perhaps other early life factors, such as maternal diet, feeding 
methods, pre-term versus full term deliveries (19), may influence MPOD and in turn may be 
contributing to the seen relationships. Future studies should further this area of research by 
including these factors in their data analysis. 
 Lutein and zeaxanthin have received considerable attention for their impact on visual 
health, and more recently on cognitive health in the elderly (20-24). However, the influence of 
lutein and zeaxanthin on cognitive health in preadolescence has received little attention in 
comparison (118, 119). Although dietary carotenoids have not been investigated directly for their 
effect on academic performance, studies have been conducted on other dietary aspects and their 
impact on academic performance. Overall diet quality has been demonstrated to impact academic 
performance in children. A study completed in 5th graders showed a positive association of diet 
quality and academic performance (27). Within overall diet quality, it was found that students 
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with an increased intake of fruits and vegetables, sources high in carotenoids, was associated 
with their academic performance (27). Additionally, dietary fibers, nutrients found abundantly in 
fruits and vegetables, have been related to childhood cognitive function (112). After placement 
into a free school breakfast program that decreased nutritional risks in students, improvements in 
math grades were observed. (28). As dietary carotenoids are a hallmark of higher quality diets, 
our results are consistent with previous studies suggesting a role for diet in childhood cognitive 
function. This thesis does however add to the current literature, as it provides support for the 
neurocognitive potential of the macular carotenoids, even after adjusting for sex, IQ, whole body 
percent fat, and fat free mass VO2max, measures that have been previously demonstrated to 
relate to academic achievement in preadolescence (111, 129-132). 
  The macular carotenoids, lutein and zeaxanthin measured via MPOD, demonstrated a 
significant relationship with academic performance among preadolescents congruent with our a 
priori hypothesis based on the preferential accumulation of lutein in the brain (19, 20). 
Significant associations have been shown between lutein and cognition in the elderly. MPOD has 
been shown to relate to cognition in adults (20, 22, 23). Additionally, supplementation with 
lutein and zeaxanthin has been shown to improve cognitive function in healthy older women 
(24).   
 Carotenoids may exert their effects through several mechanisms in the brain to improve 
cognitive function. The brain is especially vulnerable to free radical damage due to its relatively 
low antioxidant content, high polyunsaturated fatty acids (PUFA) concentration, and high 
metabolic activity (100). Carotenoids function as antioxidants and anti-inflammatory agents 
(133).  These properties provide potential mechanisms for them to help improve cognition in 
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children, especially as their brains are still undergoing extensive development in both structure 
and function (102, 103).  
 Limitations of this study include the correlational study design. Thus, placebo-controlled 
interventions should be conducted to further investigate this relationship. Additionally, MPOD 
measurement via heterochromatic flicker photometry has been shown to only be moderately 
reliable in children, thus the use of a better validated technique, such as fundus reflectometry or 
fundus autofluorescence, would help to confirm these findings (116). However, both of these 
techniques do come with their own inherent limitations such as the need to dilate pupils, 
unpleasant light levels, the need to align the equipment precisely, and the higher cost of 
equipment (116). As such, further investigation into improving the reliability and validity of HFP 
in children should be a goal of future studies. Although not completely genetically controlled 
(134), there are some potential contributing genetic factors to the accumulation of lutein and 
zeaxanthin as macular pigments that is made clear from supplementation studies demonstrating 
that some people are non-responders to supplementation (30). Thus, another potential limitation 
of this thesis is not measuring genes that may contribute to variation in MPOD (135).   
 Due to the rapid rise in childhood obesity, links between the detrimental effects of excess 
fat mass, physical inactivity, and overall diet quality on childhood cognition are becoming 
clearer (27, 136-138). However, the effect of specific nutrients on cognition of children without 
nutritional deficiencies has not been thoroughly investigated. This thesis serves the purpose of 
linking the carotenoids lutein and zeaxanthin to academic performance of children. Diet 
recommendations for increasing foods which are high in these nutrients have been shown to have 
other health benefits (1). Thus, improved academic performance among preadolescents may be 
yet another beneficial aspect of increasing foods high in carotenoids. Especially as academic 
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performance influences future educational attainment and income, thus impacting the future 
health and quality of life for children (25).  
 Despite their importance in the diet, national food consumption data indicate that children 
in the United States consistently fail to meet their recommended servings of fruits and 
vegetables. Indeed, less than 50% of children meet their recommendations for fruits and less than 
10% consume their recommended servings of vegetables (139). This under consumption of fruits 
and vegetables and in turn the overconsumption of foods high in calories, but low in nutritional 
value may be contributing to the rising childhood obesity rates. This is one factor contributing to 
the recent estimates that younger generations may lead shorter and less healthy lives than their 
parents, making this the first time in US history that such a trend has occurred (140). Therefore, 
public health initiatives should continue to promote fruit and vegetable intake as it has beneficial 
aspects across an array of health domains (1), and this work shows another potential benefit, 
improved academic performance among preadolescents, of consuming carotenoids on a regular 
basis. Additionally, as there is currently no Daily Reference Intake (DRI) for lutein or 
zeaxanthin, studies demonstrating their affects take them one step closer to being able to undergo 
the process for obtaining a DRI value. Once they have a DRI, then they can be incorporated into 
public health policy and the knowledge of their benefits will become more available for the 
general public.  
 Further consideration should be made to other early life factors that may be contributing 
to higher MPOD. As seen in the subsample of our population, diet did not mediate the 
relationship of academics to MPOD; other factors may be equally, or of more importance in 
determining children’s MPOD values. Future studies should continue to investigate potential 
contributing factors to continue to tell a fuller story on the relationships of MPOD to academics 
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and other confounding variables that may be present. Then, these factors may be able to be 
focused on in early life to improve academic achievement in preadolescence.  
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CHAPTER 6 – CONCLUSIONS 
 Support for a positive relationship between dietary lutein and zeaxanthin intake and 
MPOD levels, as well as positive relationships between MPOD and academic achievement 
scores has been provided in this thesis work. As macular pigment levels serve as a biomarker for 
lutein and zeaxanthin concentration in the brain (18), the positive associations between MPOD 
and cognition found in this thesis are not entirely surprising. Additionally, as macular pigment 
can be impacted by diet in most of the population (30), dietary interventions that increase their 
concentrations are possible. If these interventions would help improve cognition in 
preadolescence, they may serve as a useful tool for improving academic performance. However, 
continued research is needed to gain a more causal understanding of the relationship between 
MPOD and cognition in children, including, but not limited to the inclusion of early life factors 
in data analysis.
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 Health History & Demographics Questionnaire 
Please answer the following questions to the best of your ability. 
General Information 
 
1. What was your child’s date of birth? _________/_________/_________ 
2. Was your child born before 37 weeks of pregnancy?            □ Yes   □ No 
3. At what week of pregnancy was your child born? __________ weeks 
4. What was your child’s birth weight? __________lbs  __________oz 
5. Did the mother of your child suffer from any medical condition while she was pregnant?     
□ Yes   □ No       If yes, what condition? 
6. What is your child’s current age? _______________ 
7. What is your child’s current (or recently completed) Grade Level? _______________ 
8. What is your child’s sex?           □ Male           □ Female 
9. Which is your child’s dominant hand?          □ Right         □ Left          □No Preference 
10. Is your child color blind?           □ Yes   □ No 
11. Does your child wear contacts or glasses?           □ Yes   □ No 
If yes, what was their prescription for? 
Demographics 
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1. Does your child live with their biological parents?           □ Yes   □ No 
2. Does your child live in a single parent/guardian household?           □ Yes   □ No 
3. Does your child live with their Mother or a Female guardian?           □ Yes   □ No 
4. Does your child’s Mother/Female guardian work?           □ Yes   □ No 
5. What is the highest level of education obtained by your child’s Mother/Female 
guardian? 
a) Did not complete high school 
b) High School Graduate 
c) Some College 
d) Bachelor Degree 
e) Advanced Degree 
 
6. Does your child live with their Father or a Male guardian?           □ Yes   □ No 
7. Does your child’s Father/Male guardian work?           □ Yes   □ No 
8. What is the highest level of education obtained by your child’s Father/Male guardian? 
a) Did not complete high school 
b) High School Graduate 
c) Some College 
d) Bachelor Degree 
e) Advanced Degree 
 
9. How many other children (under the age of 18) live with your child? _______________ 
How old are they? _______________ 
What is their sex? _______________ 
10. How many biological siblings does your child have? _______________ 
11. Does your child receive free or reduced-price school lunch?           □ Yes   □ No 
12. Do you consider yourself to be Hispanic or Latino (A person of Mexican, Puerto Rican, Cuban, 
South or Central American, or other Spanish culture or origin, regardless of race)?        □ Yes   □ No 
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13. What race / ethnicity do you consider your child? 
a) American Indian or Alaska Native 
b) Asian 
c) Black or African American 
d) Native Hawaiian or other Pacific Islander 
e) White or Caucasian 
f) Mixed or Other 
 
 
 
14. What is your approximate household income? 
a) <10,000 
b) 10,000-20,000 
c) 21,000-30,000 
d) 31,000-40,000 
e) 41,000-50,000 
f) 51,000-60,000 
g) 61,000-70,000 
h) 71,000-80,000 
i) 81,000-90,000 
j) 91,000-100,000 
k) 100,000+ 
 
 
Activities 
 
1. Does your child participate in musical activities?           □ Yes   □ No 
If yes: 
Does your child play an instrument?           □ Yes   □ No 
If so, what instrument(s)?  
Does your child participate in choir?           □ Yes   □ No 
How many hours a week does your child spend participating in musical activities? 
 
2. Does your child participate in religious activities?           □ Yes   □ No 
If yes, how many hours a week does your child spend participating in religious 
activities? 
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3. Does your child participate in sports activities?           □ Yes   □ No 
If yes: 
Does your child participate in formal youth sports?           □ Yes   □ No 
In what activities does your child participate? 
 
4. Has your child attended regular afterschool care outside of your home in the last year?           
□ Yes   □ No 
Habits 
 
1. How much time does your child spend watching television on an average day during the week? 
a) < 1 Hour per Day 
b) 1 to 2 Hours per Day 
c) 2 to 3 Hours per Day 
d) 3 to 4 Hours per Day 
e) 4 to 5 Hours per Day 
f) 5 to 6 Hours per Day 
g) 6 to 7 Hours per Day 
h) 7 to 8 Hours per day 
i) > 8 Hours per Day 
 
2. How much time does your child spend watching television on an average day during the weekend? 
a) < 1 Hour per Day 
b) 1 to 2 Hours per Day 
c) 2 to 3 Hours per Day 
d) 3 to 4 Hours per Day 
e) 4 to 5 Hours per Day 
f) 5 to 6 Hours per Day 
g) 6 to 7 Hours per Day 
h) 7 to 8 Hours per day 
i) > 8 Hours per Day 
 
3. How much time does your child spend on a computer on an average day during the week? 
a) < 1 Hour per Day 
b) 1 to 2 Hours per Day 
c) 2 to 3 Hours per Day 
d) 3 to 4 Hours per Day 
e) 4 to 5 Hours per Day 
f) 5 to 6 Hours per Day 
g) 6 to 7 Hours per Day 
h) 7 to 8 Hours per day 
i) > 8 Hours per Day 
 
4. How much time does your child spend on a computer on an average day during the weekend? 
a) < 1 Hour per Day 
b) 1 to 2 Hours per Day 
c) 2 to 3 Hours per Day 
d) 3 to 4 Hours per Day 
f) 5 to 6 Hours per Day 
g) 6 to 7 Hours per Day 
h) 7 to 8 Hours per day 
i) > 8 Hours per Day 
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e) 4 to 5 Hours per Day 
 
5. How much time does your child spend playing video games on an average during the week? 
a) < 1 Hour per Day 
b) 1 to 2 Hours per Day 
c) 2 to 3 Hours per Day 
d) 3 to 4 Hours per Day 
e) 4 to 5 Hours per Day 
f) 5 to 6 Hours per Day 
g) 6 to 7 Hours per Day 
h) 7 to 8 Hours per day 
i) > 8 Hours per Day 
 
6. How much time does your child spend playing video games on an average during the weekend? 
a) < 1 Hour per Day 
b) 1 to 2 Hours per Day 
c) 2 to 3 Hours per Day 
d) 3 to 4 Hours per Day 
e) 4 to 5 Hours per Day 
f) 5 to 6 Hours per Day 
g) 6 to 7 Hours per Day 
h) 7 to 8 Hours per day 
i) > 8 Hours per Day 
 
7. How much time does your child spend being physically active on an average during the week? 
a) < 1 Hour per Day 
b) 1 to 2 Hours per Day 
c) 2 to 3 Hours per Day 
d) 3 to 4 Hours per Day 
e) 4 to 5 Hours per Day 
f) 5 to 6 Hours per Day 
g) 6 to 7 Hours per Day 
h) 7 to 8 Hours per day 
i) > 8 Hours per Day 
 
8. How much time does your child spend being physically active on an average during the weekend? 
a) < 1 Hour per Day 
b) 1 to 2 Hours per Day 
c) 2 to 3 Hours per Day 
d) 3 to 4 Hours per Day 
e) 4 to 5 Hours per Day 
f) 5 to 6 Hours per Day 
g) 6 to 7 Hours per Day 
h) 7 to 8 Hours per day 
i) > 8 Hours per Day 
 
9. How much sleep does your child regularly get? 
a) < 5 Hours per Day 
b) 5 to 6 Hours per Day 
c) 6 to 7 Hours per Day 
d) 7 to 8 Hours per Day 
e) 8 to 9 Hours per Day 
f) 9 to 10 Hours per Day 
g) > 10 Hours per Day 
 
10. How much sleep did your child get last night? 
a) < 5 Hours 
b) 5 to 6 Hours 
c) 6 to 7 Hours 
d) 7 to 8 Hours 
e) 8 to 9 Hours 
f) 9 to 10 Hours 
g) > 10 Hours 
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11. How many caffeinated soft drinks does your child regularly drink in a day? 
□ None        □ One      □ Two      □ Three or more 
 
12. How many cups of tea does your child regularly drink in a day? 
□ None        □ One      □ Two      □ Three or more 
 
13. How often would you rate your child’s stress level as HIGH?  
□ Occasionally        □ Frequently      □ Constantly 
 
When was the last time your child: 
Had a caffeinated substance? 
Ate a meal or a snack? 
What did s/he have to eat? 
Exercised? 
What type of exercise? 
How long did s/he exercise for? 
How intense did s/he work out? 
 
General Health 
 
1. When was the last time your child saw a doctor?         _____________________ 
2. Does your child have any allergies?           □ Yes   □ No 
3. Does your child have any food allergies? □ Yes   □ No ___________________ 
Is your child allergic to milk? □ Yes   □ No 
Is your child allergic to soy? □ Yes   □ No 
Please list any other allergies your child may have:___________________________ 
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 4. Is your child allowed to consume foods that contain animal products? 
           □ Yes               □ No (my child follows a strictly plant-based/vegan diet) 
5. Was your child breastfed?      □ Yes   □ No 
If yes, what was the duration of exclusive (no formula at all) breast feeding? ____ 
months 
At what age did your child stop drinking any breast milk? ____months  
 
6. At what age was infant formula introduced to your child? ________months 
 
7. How old was your child when he/she was first fed something (e.g., cereals, pureed 
foods, solid foods) other than breast milk or formula?  _______ months 
8. Has your child ever been diagnosed with dyslexia?           □ Yes   □ No 
9. Has your child ever been diagnosed with an attentional disorder?           □ Yes   □ No 
10. Has your child ever been diagnosed with asthma?           □ Yes   □ No 
11. Is your child epileptic?           □ Yes   □ No 
12. Is your child diabetic?           □ Yes   □ No 
If so please explain: 
13. Has your child been diagnosed with any kind of cancer?           □ Yes   □ No 
If so please explain: 
14. Does your child have hearing loss or wear a hearing aid?           □ Yes   □ No 
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15. Has your child been hospitalized within the last 6 months?           □ Yes   □ No 
If so please explain: 
 
16. Has your child ever lost consciousness as a result of hitting their head?    □ Yes   □ No 
If yes: 
When did this occur? 
Where did s/he hit his/her head? 
How long was s/he unconscious? 
17. Has your child ever lost consciousness as a result of any other type of injury or seizure?           
□ Yes   □ No 
If yes: 
When did this occur? 
How long was s/he unconscious? 
 
Medications/Supplements 
Medications:  Is your child presently taking or have they taken any of the following medications within 
the past two months?  Please circle your answer. 
 
Asprin, Bufferin, Anacin 
Blood Pressure pills 
Cortisone 
Cough Medicine 
Digitalis 
Hormones 
Insulin or Diabetic pills 
Iron or poor blood medications 
Laxatives 
Sleeping pills 
Tranquilizers 
Weight reducing pills 
Blood thinning pills 
Dilantin 
Allergy Shots 
Water pills 
Antibiotics 
Barbiturates 
Phenobarbital 
Thyroid medicine 
 
Other(s):________________________________________________________ 
 
1. Does your child take Ginkgo Biloba supplements?           □ Yes   □ No 
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If yes: 
When was the last time they took the supplement? 
What dose of the supplement did they take? 
 
2. Does your child take Iron supplements?           □ Yes   □ No 
If yes: 
When was the last time they took the supplement? 
What dose of the supplement did they take? 
3. Does your child take any stimulants or sedatives?           □ Yes   □ No 
If yes: 
What do they take? 
When was the last time they took it? 
What dose of it did they take? 
 
Cardiovascular Health 
 
Does your child have any of the following: 
1. □ Yes   □ No         Pain or discomfort in the chest, neck, jaw, arms, or other areas that 
may be related to poor circulation. 
2. □ Yes   □ No         Heartbeats or palpitations that feel more frequent or forceful than 
usual or feeling that your heart is beating very rapidly. 
3. □ Yes   □ No         Unusual dizziness or fainting. 
4. □ Yes   □ No         Shortness of breath while lying flat or a sudden difficulty in 
breathing that wakes them up while sleeping. 
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5. □ Yes   □ No         Shortness of breath at rest or with mild exertion (such as walking 
two blocks). 
6. □ Yes   □ No         Feeling lame or pain in the legs brought on by walking. 
7. □ Yes   □ No         A known heart murmur. 
8. □ Yes   □ No         Unusual fatigue with usual activities. 
9. □ Yes   □ No         Has any male in your immediate family had a 
heart attack or sudden death before the age of 55? 
10. □ Yes   □ No         Has any female in your immediate family 
had a heart attack or sudden death before the age of 65? 
11. □ Yes   □ No         Do you have family history of heart 
disease? 
12. □ Yes   □ No         Do you have family history of lung 
disease? 
13. □ Yes   □ No         Do you have family history of diabetes? 
14. □ Yes   □ No         Do you have family history of strokes? 
15. □ Yes   □ No         Has your child been diagnosed with a past or present 
cardiovascular disease?  
16. □ Yes   □ No        Does your child have any significant heart rhythm disorder?  
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17. □ Yes   □ No        Has your child been diagnosed with hypertension?  
18. □ Yes   □ No        Has your child been diagnosed with peripheral vascular disease?  
Other 
 
Is there anything else you feel we should know about your child’s current/past health?  
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Tanner Staging Questionnaire 
On each side of the line, please circle the number that best represents your child’s pubertal status. 
 
1.   1.  
 The breasts are flat.   No hairs. 
2.  
 
 
 
 
 2.  
 The breasts form small mounds.   Very little hair. 
3.   3.  
 The breasts form larger mounds than in 2.   Quite a lot of hair. 
4.  
 
 
 4.  
 The nipple and the surrounding part (the Areola) make 
up a mound that sticks up above the breast. 
  The hair has not spread over the 
thighs. 
5.  
 
 
 
 
 5.  
 Only the nipple sticks out beyond the breast.   The hair has spread over the thighs. 
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Tanner Staging Questionnaire 
On each side of the line, please circle the number that best represents your child’s pubertal status. 
 
1.   1.  
 Scrotum and penis are the same size.   No hairs. 
2.   2.  
 The scrotum has lowered a bit and the penis is a 
little larger. 
  Very little hair. 
3.   3.  
 The penis is longer and the scrotum is larger.   Quite a lot of hair. 
4.  
 
 
 4.  
 The penis is longer and wider; the scrotum is 
darker and bigger than before. 
  The hair has not spread over the thighs. 
5.   5.  
 The penis and scrotum are the size and shape of 
an adult. 
  The hair has spread over the thighs. 
 
Penis Scrotum 
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 Instructions for Recording the 3-Day Food 
Diary 
 
1. Record everything you ate or drank during the 24-hour time period indicated (12:01 a.m. to 
midnight). Repeat this for a total of 3 days (2 week days, 1 weekend day). 
 
2. To the best of your ability, describe combination or mixed dishes that were eaten.  For 
example, what ingredients were included on that piece of pizza?  Was it thick or thin crust?  
Include brand names if known. 
 
3. Describe the amounts consumed in terms appropriate for that item.  For example:  ounces 
(cups) of milk, tablespoons of French dressing, slices of bread, pieces of fruit, etc.  If you had 
a piece of pizza, how big was it in inches or sections, etc.? Record exact amounts to the best 
of your ability. 
Sample Breakfast 
Raisin bran cereal   1 cup. 
2% milk    6 oz. 
Orange    1 medium size, 3” diameter 
Toast (whole wheat)   1 slice 
     with butter    1 teaspoon 
     with strawberry jam  1 tablespoon 
Black coffee    1 cup (8 oz.) 
     with sugar    2 teaspoons 
 
4. Remember to include beverages, and anything you may add to them, such as milk or 
sweetener. 
 
5. Remember to include anything added to a food after it is prepared, such as margarine, salt, 
catsup, mustard and the estimated amount. 
 
6. If you need additional space, use the back of the paper or attach additional sheets. 
 
7. Answer the question at the bottom of the day’s record.  (Does this day’s record represent 
your usual food intake?  ___ Yes  ___ No).  If your answer is no, explain why it wasn’t 
representative.  Were you ill or are you on a special diet?  Did you have unexpected guests 
and you took them out to dinner? 
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Portion Size Examples 
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DAY 1 
3 Day Food Diary 
Date __________       Day of the week: __________________  
 
       Circle One: Weekday      Weekend 
Does this day’s record represent your usual days’ intake?  _____ yes   _____ no 
If no, explain why not _________________________________________________  
  
Time/ 
Meal 
Food, Beverage, 
Condiments 
Amount Eaten  
(grams, cups, tsp, Tbsp, 
oz, etc) 
Brand/Name 
How 
prepared 
Home 
/Out 
TV/ 
Comput
er/ 
Video 
Game 
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DAY 2 
3 Day Food Diary 
Date __________       Day of the week: __________________  
       Circle One: Weekday      Weekend 
Does this day’s record represent your usual days’ intake?  _____ yes   _____ no 
If no, explain why not _________________________________________________
Time/ 
Meal 
Food, Beverage, 
Condiments 
Amount Eaten  
(grams, cups, tsp, Tbsp, 
oz, etc) 
Brand/Name 
How 
prepared 
Home 
/Out 
TV/ 
Comput
er/ 
Video 
Game 
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DAY 3 
3 Day Food Diary 
Date __________       Day of the week: __________________  
      Circle One: Weekday      Weekend 
 
Does this day’s record represent your usual days’ intake?  _____ yes   _____ no 
If no, explain why not _________________________________________________ 
 
 
 
 
Time/ 
Meal 
Food, Beverage, 
Condiments 
Amount Eaten  
(grams, cups, tsp, Tbsp, 
oz, etc) 
Brand/Name 
How 
prepared 
Home 
/Out 
TV/ 
Comput
er/ 
Video 
Game 
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MPOD 
Study: ___________ 
Age: ________      Date: ___________      Length of Test: _________Experimenter: _______ 
 
Indicate which eye the child is using:  □ Left    □ Right   Point in Testing:  _______ 
 
Has any eye injury occurred in the child’s past (i.e., anything that required a visit to ER or family 
physician)?  □No □Yes:_______________ 
Determining Critical Flicker Fusion Frequency:  
 
_______ Hz  ________Hz ________Hz ________Hz ________Hz    Average CFF: ________ 
 
Suggested Conversion Guidelines:  
CFF Foveal LFF Parafoveal LFF 
10-12 11-12 6 
13-16 12-13 6-7 
17-20 13-14 7-8 
21-25 14-16 8-9 
25+ 16-17 9-10 
 
Foveal measurement (Radiance values):  
Starting LFF: _______   Ending LFF: _______  
(“never stops flickering” = rate up; no flicker at points that vary by more than 100 = rate down) 
     (end with Trial 3 if average range of Trial 1-3 is < +/- 100) 
Trial 1: (start @ 
3000, work down) 
Trial 2: (start @ 0, 
work up) 
Trial 3: Trial 4: Trial 5: 
 
________ 
 
________ 
 
________ 
 
________ 
 
________ 
 
Parafoveal measurement (Radiance values): (should be between ~ 200 and 600) 
Starting LFF: _______   Ending LFF: _______ 
(“never stops flickering” = rate up; no flicker at points that vary by more than 100 = rate down) 
     (end with Trial 3 if average range of Trial 1-3 is < +/- 100) 
Trial 1: (start @ 
1000, work down) 
Trial 2: (start @ 0, 
work up) 
Trial 3: Trial 4: Trial 5: 
 
________ 
 
________ 
 
________ 
 
________ 
 
________ 
 
Macular pigment optical density:  Standard deviation: 
 
________ 
 
________ 
Notes (e.g., subject could not see disk, could not focus on red dot, etc.):  
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